1. Anti-alphavbeta3 antibodies in chronic immune thrombocytopenic purpura
- Author
-
Kosugi S, Yoshiaki Tomiyama, Honda S, Kashiwagi H, Shiraga M, Tadokoro S, Kiyoi T, Kurata Y, and Matsuzawa Y
- Subjects
Blood Platelets ,Male ,Purpura, Thrombocytopenic, Idiopathic ,Umbilical Veins ,Platelet Count ,Enzyme-Linked Immunosorbent Assay ,Platelet Glycoprotein GPIIb-IIIa Complex ,Cross Reactions ,Cytotoxicity Tests, Immunologic ,Humans ,Female ,Receptors, Vitronectin ,Endothelium, Vascular ,Autoantibodies - Abstract
In chronic immune thrombocytopenic purpura (ITP), anti-GPIIb-IIIa (alphaIIbbeta3) autoantibodies have been detected in serum and/or platelet-associated IgG (PAIgG) and considered as one of the major causes. We examined whether anti-alphavbeta3 antibodies might be present in ITP cases because of the similarity between alphavbeta3 and GPIIb-IIIa (alphaIIbbeta3). Modified antigen capture ELISA (MACE) using human umbilical vein endothelial cells (HUVEC) showed the presence of serum anti-alphavbeta3 antibodies in 23 of 80 ITP patients (29%). Cross-adsorption studies between platelets and HUVEC demonstrated that most of anti-alphavbeta3 and anti-GPIIb-IIIa antibodies exclusively reacted with alphavbeta3 and GPIIb-IIIa, respectively. Platelet-associated anti-GPIIb-IIIa antibodies did not react with alphavbeta3, either. Interestingly, patients having anti-alphavbeta3 antibodies showed significantly lower platelet counts than negative patients. These results indicate the serum anti-alphavbeta3 antibodies are different ones from the classical anti-GPIIb-IIIa (alphaIIbbeta3) antibodies and would provide a new insight into the pathophysiology of ITP as well as the autoantigenic epitopes on beta3 integrins.
- Published
- 2001